If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Roberto Massimo Lemoli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Autologous Transplantation Medicine & Life Sciences
Granulocyte Colony-Stimulating Factor Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences
Hematopoietic Stem Cells Medicine & Life Sciences
Stem Cells Medicine & Life Sciences
Dendritic Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1987 2019

A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia

Marcolin, R., Guolo, F., Minetto, P., Clavio, M., Manconi, L., Ballerini, F., Carli, A., Passannante, M., Colombo, N., Carminati, E., Pugliese, G., Tedone, E., Contini, P., Mangerini, R., Kunkl, A., Miglino, M., Cagnetta, A., Cea, M., Gobbi, M. & Lemoli, R. M., Nov 1 2019, In : Leukemia Research. 86, 106223.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Mutation
HLA-DR Antigens
Karyotype
Multivariate Analysis

Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas

Manconi, L., Coviello, E., Canale, F., Giannoni, L., Minetto, P., Guolo, F., Clavio, M., Marcolin, R., Cea, M., Cagnetta, A., Gobbi, M., Miglino, M., Ballerini, F. & Lemoli, R. M., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

oxaliplatin
Lymphoma, Large B-Cell, Diffuse
Cytarabine
Cell- and Tissue-Based Therapy
Dexamethasone

Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib

Palandri, F., Palumbo, G. A., Abruzzese, E., Iurlo, A., Polverelli, N., Elli, E., Bonifacio, M., Bergamaschi, M., Martino, B., Tiribelli, M., Benevolo, G., Tieghi, A., Sgherza, N., Isidori, A., Binotto, G., Crugnola, M., Heidel, F., Cavazzini, F., Bosi, C., Auteri, G. & 10 others, Cattaneo, D., Foà, R., Lemoli, R. M., Cuneo, A., Krampera, M., Bartoletti, D., Cavo, M., Vianelli, N., Breccia, M. & Latagliata, R., Jan 1 2019, In : Hematological Oncology.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Leukemia
Spleen
INCB018424
Survival

Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib

Breccia, M., Bartoletti, D., Bonifacio, M., Palumbo, G. A., Polverelli, N., Abruzzese, E., Bergamaschi, M., Tieghi, A., Tiribelli, M., Iurlo, A., Cavazzini, F., Sgherza, N., Binotto, G., Isidori, A., D’Adda, M., Crugnola, M., Bosi, C., Heidel, F., Molica, M., Scaffidi, L. & 14 others, Cattaneo, D., Latagliata, R., Auteri, G., Lemoli, R. M., Fanin, R., Russo, D., Aversa, F., Cuneo, A., Semenzato, G., Catani, L., Cavo, M., Vianelli, N., Foà, R. & Palandri, F., 2019, In : Annals of Hematology. 98, 4, p. 889-896

Research output: Contribution to journalArticle

Primary Myelofibrosis
Comorbidity
Body Mass Index
Spleen
Anemia